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Nisin P is a natural nisin variant, the genetic determinants for which were previously identified in 
the genomes of two Streptococcus species, albeit with no confirmed evidence of production. Here 
we describe Streptococcus agalactiae DPC7040, a human faecal isolate, which exhibits antimicrobial 
activity against a panel of gut and food isolates by virtue of producing nisin P. Nisin P was purified, and 
its predicted structure was confirmed by nanoLC-MS/MS, with both the fully modified peptide and a 
variant without rings B and E being identified. Additionally, we compared its spectrum of inhibition 
and minimum inhibitory concentration (MIC) with that of nisin A and its antimicrobial effect in a faecal 
fermentation in comparison with nisin A and H. We found that its antimicrobial activity was less potent 
than nisin A and H, and we propose a link between this reduced activity and the peptide structure.
Nisin is a small peptide with antimicrobial activity against a wide range of pathogenic bacteria. It was originally 
sourced from a Lactococcus lactis subsp. lactis isolated from a dairy product1 and is classified as a class I bacteri-
ocin, as it is ribosomally synthesised and post-translationally modified2. Nisin has been studied extensively and 
has a wide range of applications in the food industry, biomedicine, veterinary and research fields3–6. It is approved 
as a food preservative by the Food and Agriculture Organization and is Generally Recognized As Safe (GRAS) by 
the United States Food and Drug Administration4.
Structurally, nisin is classified as a lantibiotic because it contains lanthionine (Lan), an unusual amino acid 
formed by two alanine residues linked by a sulphur atom through their β-carbon4. Other unusual amino acids 
present in nisin are dehydroalanine (Dha), dehydrobutyrine (Dhb) and β-methyl-lanthionine4. Nisin activity and 
stability are closely related to its structure and can be altered by pH changes. Increasing pH results in decreasing 
activity as a consequence of alterations in structure, therefore, nisin is more stable at lower pH. Nisin is heat-stable 
and also exhibits high stability at low temperatures, which makes it suitable for freeze-storage7.
Nisin has nine reported natural variants (Fig. 1, Table 1). Nisin A is the most studied nisin as it was the first one 
purified8. Nisin Z is considered the first natural variant of nisin A; it differs in the presence of an asparagine amino 
acid in position 27 instead of a histidine residue9. This substitution has very little effect on antimicrobial activity, 
thermal and pH stability compared to nisin A, but affects the solubility of the molecule, with nisin Z being more 
soluble at neutral pH10. A study of its distribution also revealed that nisin Z is more widespread than nisin A10. 
Nisin F, produced by L. lactis isolated from a fish gut, also has asparagine and valine in positions 21 and 3011. 
Nisin Q was identified in an environmental L. lactis isolate and differs from nisin A due to the presence of valine, 
leucine, asparagine and valine in positions 15, 21, 27 and 30, respectively12. Nisin U and U2 were the first variants 
found to be produced by a species other than L. lactis13; they are produced by Streptococcus uberis strain 42, iso-
lated from bovine mammary secretions14, and differ to nisin A by nine and ten amino acids, respectively. Nisin 
H, produced by Streptococcus hyointestinalis was the first variant isolated from a mammalian gastrointestinal (GI) 
tract (porcine)15 and has five different amino acids at positions 1, 6, 18, 21 and 31. In 2017, a nisin O operon has 
been reported in Blautia obeum A2–162 isolated from a human GI tract16. Unusually this operon encodes 4 pep-
tides, the first 3 being identical and exhibiting similarity to nisin U, and the fourth showing the highest divergence 
from nisin A. Most interestingly, a further example of a multi-peptide operon from Blautia producta has recently 
been described and shown to be important in resistance against vancomycin-resistant Enterococcus in an animal 
model17. The nisin P operon was previously identified in the genomes of two Streptococcus species15 but its activity 
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has not been reported before. Nisin P is predicted to be three amino acids shorter than nisin A at the C-terminus, 
making it the shortest natural nisin variant reported to date, and differs to nisin A in ten amino acids (Fig. 1).
Here we establish that Streptococcus agalactiae DPC7040, isolated from human faeces, contains a nisin P gene 
cluster and represents the first example of a strain that produces nisin P. In this study we assess the cross immunity 
of other nisin producers to nisin P, determine its activity in vitro compared to nisin A and H and investigate its 
ability to induce the nisin A promoter. In addition, a faecal fermentation experiment was conducted to determine 
how a human faecal microbiota was affected by the presence of nisin A, H and P.
Figure 1. Predicted ring structures of nisin natural variants. Residues highlighted in yellow depict amino acid 
changes when compared to nisin A.
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Results
S. agalactiae DPC7040 localization within the S. agalactiae species. The constructed S. agalactiae 
phylogenetic tree showed no specificity for the body isolation site. The 13 genomes of S. agalactiae that were 
reported to have stool origin were spread over the whole species and showed no specific clustering (Fig. 2A). 
Scoary analysis showed that there were no genes associated to the gut isolates with 100% sensitivity and speci-
ficity. However, there were genes that were significantly associated (using a Bonferroni-adjusted p value <0.05) 
with stool isolates, either by presence or absence (Table S1). The PCoA constructed from accessory gene content 
showed some level of differential clustering between S. agalactiae isolates of human origin and isolates from 
non-human animals (Fig. 2B). No annotation for LanB or LanC proteins was found in the genomes of the other 
stool S. agalactiae isolates, indicating that, among genome-sequenced strains, the nisin P operon is only present 
in S. agalactiae DPC7040.
Characterization of the nisin P gene cluster from S. agalactiae DPC7040. The prototypical nisin A 
gene cluster consists of the structural gene nisA, followed by nisBTCIPRKFEG18. The nisin P gene cluster in S. aga-
lactiae DPC7040 has a similar gene order but the nipPRKFEG genes are located to the front of the nipA structural 
gene, a phenomenon which also occurs in the nisin U gene cluster16 (Fig. 3). The same gene order was observed 
when the nisin P gene cluster was first reported in the genome of Streptococcus suis19.
Extraction and purification of nisin P. Nisin P and nisin H are produced by streptococci that require 
complex media (BHI and MRS, respectively) for growth and bacteriocin production. Nisin P production by S. 
agalactiae DPC7040 required initial induction by nisin A, taking advantage of the inducing activity of nisin pep-
tides20, but was subsequently self-inducing. The highest antimicrobial activity was achieved when S. agalactiae 
DPC7040 was cultured in BHI broth under anaerobic conditions for 48 h. Activity in well diffusion assays was less 
than nisin A (Fig. 4A). Purification was achieved by a four-step process using Amberlite XAD16N, SP Sepharose, 
Nisin variant First reported in Reference
A L. lactis subsp. lactis 1
Z L. lactis strain NIZO 22186 (dairy product) 9
Q L. lactis 61–14 (Japanese river water) 12
F L. lactis F10 (freshwater catfish) 11
U and U2 S. uberis strain 42 (bovine mammary secretions) 13
P Streptococcus gallolyticus subsp. pasteurianus 17
H S. hyointestinalis DPC 6484 (porcine intestine) 15
O Blautia obeum A2–162 (human GI tract) 16
Table 1. Summary of nisin variants reported in the literature.
Figure 2. (A) S. agalactiae phylogenetic tree of all genomes publicly available in PATRIC database 30/08/2019, 
constructed with PhyloPhlAn (v. 0.99), huttenhower.sph.harvard.edu/phylophlan. The 12 stool isolates are 
marked in red and S. agalactiae DPC7040 is yellow. (B) PCoA based on the presence/absence of accessory genes 
(genes present in less than 90% of the genomes) in the S. agalactiae pangenome, constructed with R (v. 3.4.4) 
www.r-project.org/.
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C18 SPE and Reversed phase HPLC. Overall yield was very low, i.e., 0.2–0.35 mg/l for nisin H and 0.1–0.2 mg/l for 
nisin P (Fig. 4), while the yield for nisin A production is typically 3–4 mg/l. The lower yield obtained for nisin H 
and P could be partially due to less efficient purification, but it is most likely due to lower cell numbers, typically 
in the range of 108 cfu/ml for S. hyointestinalis and S. agalactiae compared to 109 cfu/ml for the nisin A producer, 
L. lactis NZ9000.
Prediction of the nisin P structure. Purified nisin P peptide was tested to confirm that the expected 
peptide was intact (Fig. 5A). The extracted-ion chromatogram (XIC) shows the recovered nisin P at 9.56 min 
(Fig. 5B). The base peak intensity chromatogram shows that some impurities were found (12.55 min), but the 
presence of intact nisin P was confirmed (Fig. 5C).
Possible modifications were further assessed by the analysis of the eluted samples, that showed a series of 
charge states ranging from 5+ to 2+ (Fig. 5D). The most abundant charge state was 4+. A more detailed analysis 
of this isotope pattern showed a mass value of 2987.3841 Da, that matched the expected mass of fully dehydrated 
(−8 H2O) nisin P (2987.3922 Da) (Fig. 5E). Additional peaks have an addition of 4 m/z corresponding to 16 Da, 
suggesting oxidation. Addition of 18 Da (H2O) (or multiples) cannot be seen, meaning that the major part of nisin 
P is completely dehydrated.
After trypsin digestion, 7 exclusive unique peptides with 30 exclusive unique spectra, matching the sequence 
of nisin P with 100% probability were detected (Table 2). Those spectra cover 31 of the 31 amino acid residues of 
nisin P corresponding to 100% sequence coverage.
The presence or absence of rings can be determined by the suppression of the MS2 fragmentation within 
the regions that correspond to those rings. Two types of modifications were observed: dehydrations and 
carbamido-methylation from iodoacetamide alkylation of free cysteine residues (Fig. 6). Dehydrations (−18) 
were present on S and T residues (Fig. 6). Dehydrations on the T residue have been reported only in some nisin 
variants15,21. Carbamido-methylations (CAM, C+57) were observed on modified cysteine residues and are an 
indicator of the absence of a lanthionine ring, while unmodified cysteines indicate participation in ring forma-
tion. Several spectra from the complete undigested nisin P peptide appeared with no CAM modification and 
unfragmented except in the linear regions (Fig. 6). This indicates the formation of all rings. Other spectra indi-
cated incomplete ring formation. For example, the N-terminal peptide VTSKSLCTPGCK and the C-terminal 
peptides TGILMTCAIKTATCGCHFG and TATCGCHF showed CAM modifications in approximately 50% of 
the 342, 144 and 91 peptide spectra matches (PSMs) obtained by trypsin digestion with a probability of 100%. 
Another peptide, VTSKSLCTPGCKTGILMTCAIK and the full peptide, showed two modifications, with a low 
probability, in the same residues as VTSKSLCTPGCK. This indicates the absence of ring B in an estimated 50% 
of the peptides. The presence of CAM modifications in the C-terminus in peptides TGILMTCAIKTATCGCHFG 
and TATCGCHFG indicates the absence of ring E in an estimated 50% of the peptides. Based on these observa-
tions, the structure of nisin P was confirmed (Fig. 7).
pH stability of nisin A, P and H. The antimicrobial activities of nisin A, P and H stored at pH 3, 5, 6, 7, and 
8 for 24, 48 and 72 h were compared by well-diffusion assay using L. bulgaricus LMG 6901 as an indicator strain 
(Fig. 8). Overall, nisin A antimicrobial activity was more stable than both P and H up to 72 h and at acidic pH. 
Nisin P was the least stable as it lost most inhibitory activity against L. bulgaricus LMG 6901 after 24 h and was 
inactive at 72 h at acidic pH, though it retained some activity at pHs 7 and 8. While nisin H activity was less stable 
than nisin A, it was more stable than nisin P as it retained more activity at 24 h, showing an optimum at pH 5, also 
at 48 and 72 h, and it showed some activity at 72 h at pHs 5, 6, 7 and 8.
Cross- immunity assays. Purified nisin P, at 0.20 mg/ml, had inhibitory activity against natural nisin A and 
U producers but not against S. hyointestinalis DPC 6484 (nisin H producer, Table 3). A lower concentration of 
nisin A (0.022 µM) was required to inhibit S. agalactiae DPC 7040 than was required to inhibit S. uberis strain 42 
(0.4 µM) and L. lactis NZ9800 (26 µM). Nisin P inhibited L. lactis NZ9800 growth at 8.5 µM and S. uberis strain 
42 at 4.25 µM. Nisin P inhibited the nisin P producer S. agalactiae DPC7040 at 17 µM. Nisin clusters encoding 
nisin A, U and P have two systems involved in immunity, one through the immunity protein NisI and the other 
one through the ABC transporter system NisFEG. However, the cluster for nisin H does not have a nisI gene15 and 
yet shows immunity to nisins P and A. A Blastp analysis was performed on the NisFEG proteins from the four 
operons. The NisF- and NisG-determinants are similar in the nisin A, P and U operons, but NshF and NshG from 
the nisin H cluster have a very low percentage of similarity to equivalent proteins from the nisin A, P and U gene 
Figure 3. Representation of the bacteriocin-encoding nisin P gene cluster compared to the nisin A operon. 
Figures indicate percentage of amino acid similarity with nisin A homologues.
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clusters (13.8%, 14.1% and 15.4% to NshF and 9%, 8.9% and 9.8% to NshG, respectively). NshE and NisE showed 
48.3% and 43.8% identity to NipE, while NsuE was more similar to NipE (79.8% identity).
Spectra of inhibition and MIC of purified nisin A and nisin P peptides against a range of strains. 
In general, purified nisin A was more potent and had a wider spectrum of inhibition than nisin P (Table 4). 
Nisin P inhibited all lactobacilli and staphylococci assayed, but inhibition was at higher concentrations than 
that observed for nisin A, which was also able to inhibit the growth of Listeria and enterococci. This is consistent 
with the spectrum of action of other nisins, that are generally potent against lactobacilli and staphylococci, and, 
indeed, Gram positive bacteria in general22.
Nisin activity in faecal fermentation. The analysis of total live bacteria in faecal samples after fermenta-
tion in the presence of two concentrations (15 µM and 50 µM) of nisin A, P and H showed different consequences 
depending on nisin type and treatment (Fig. 9). There were significant differences in the total numbers of live 
cells between the control and the treatments with nisin A, P and H, both at 8 and 24 h. Treatment with nisin A 
showed significantly less live cells compared to the controls at 8 h, showing Log10 4.234 ± 0.023 and Log10 4.792 ± 
0.01 at 15 µM and 50 µM respectively, compared to Log10 5.22 ± 0.005 in the control. At 24 h, after single nisin A 
treatments, bacterial regrowth was evident. The biggest impact was seen in samples which received a second nisin 
A treatment at 8 h, which showed Log10 4.592 ± 0.022 and Log10 5.248 ± 0.01 of live cells at 15 µM and 50 µM at 
24 h compared to Log10 5.22 ± 0.005 and Log10 5.461± 0.019 in the control. Treatments with nisin P and nisin 
H showed higher numbers of live cells with all treatments, the numbers of live cells being closer to those of total 
cells.
Activity induction. Nisin peptides also serve as auto-inducers of nisin production. The ability of nisin P, A 
and H to activate the nisin A promotor, fused to a gfp reporter, was assessed and found to differ (Table 5). The pro-
moter was more sensitive to nisin A (1 ng/ml–1 µg/ml) than nisin H (10 ng/ml – 1 µg/ml) and nisin P (100 ng/ml– 
Figure 4. (A) Inhibitory zones of nisin A and nisin P against indicator strain L. bulgaricus LMG 6901. (B) 
Purification of nisin P from S. agalactiae DPC7040 and nisin H from S. hyointestinalis DPC6484 cultures. For 
nisin P: (B) RP-HPLC chromatogram and (C) MALDI-TOF MS of active fraction number 24. Expected mass 
for nisin P is 2991 Da. For nisin H: (D) RP-HPLC chromatogram and (E) MALDI-TOF MS of active fraction 30 
showing mass corresponding to the expected nisin H mass of 3453 Da.
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10 µg/ml). Higher concentrations of nisin P were required to activate the promotor, but it continued to induce 
promoter activity at higher concentrations (10 µg/ml) whereas nisin A and H were capable of inducing the pro-
moter only up to 1 µg/ml concentrations of peptides.
Figure 5. Chromatograms from LC-MS analysis of purified nisin P. (A) Elution gradient of 1–50% 
acetonitrile in 0.1% formic acid in 9 min and to 100% acetonitrile in 1 min. (B) Extracted-ion chromatogram 
(XIC) of nisin P. (C) Base peak intensity chromatogram. (D) Raw spectrum of series of charge states from 
5+ to 2+. (E) Spectrum detail of charge state 4+, confirming expected mass of purified nisin P. The mass 
calculation is performed by multiplying by 4 the 747.8533 ion mass and removing four charges of protons 
(747.8533*4) − (4*1.007276) = 2987.3841.
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Discussion
This is the first report of production of nisin P, a natural variant of nisin, originally predicted on the basis in silico 
of genomic analysis of other two streptococcal species19,23. Initially, genes related to nisin P production were 
identified by phylogenetic categorization of LanB- and LanC-encoding enzymes in Streptococcus pasteurianus, 
and analysis of the associated lanA gene suggested the ability of this strain to produce an analogue of nisin U that 
was designated nisin P23. The gene cluster was later reported in Streptococcus suis19. The faecal isolate that was the 
focus of this study, S. agalactiae DPC7040, contained an intact nisin P cluster and produced nisin P after initial 
induction with nisin A.
The genome of S. agalactiae DPC7040 was compared with 993 S. agalactiae genomes publicly available in the 
PATRIC database. This showed that S. agalactiae did not cluster phylogenetically by human body isolation site. 
However, PCoA showed different clustering between all strains of human origin and the strains of non-human 
animal origin based on accessory gene content. No unique genome features could be associated with S. agalactiae 
DPC7040, apart from the presence of the nisin P lantibiotic cluster, which was absent from the other 12 stool 
isolates.
When nisin P activity was compared to nisin A and H, a lower inhibitory effect was observed. Nisin P showed 
a higher MIC against a panel of food and gut isolates, and also had less effect on the viability of the microbiota 
in a fermentation of human faecal material, despite being sourced from a human gut isolate. One consideration 
is differences in stability, as both nisin H and particularly nisin P lost a significant amount of activity after 24 h 
at pH 6–7. The differences in bioactivity are also likely to be contributed to by structural differences between the 
molecules. Nisin P is three amino acids shorter than nisin A at the important pore-forming C-terminal domain. 
Previously, removal of amino acids from the C-terminal region of nisin A, affecting rings D and E, showed a 
decrease of up to 100 fold of its inhibitory activity against L. lactis and 50 fold against Micrococcus luteus, suggest-
ing that different conformations might have a different outcome against different bacteria24–26. The N-terminal 
part of the nisin A molecule, that includes rings A, B and C, has been shown to be responsible for the binding of 
nisin to the membrane surface and/or its oligomerisation24. Ring B is known for being very sensitive in substitu-
tion studies and the removal of ring B in nisin A also gave a loss of activity in nisin mutants27, so the absence of 
rings B and E in 50% of the nisin P peptides may contribute to reduced activity.
Another important region involved in nisin bioactivity is the hinge region, at positions 21–2328,29. The hinge 
region consists of the three amino acids (NMK in nisin A, AIK in nisin P) that are responsible for reorientation 
after binding with lipid II to penetrate into the target cell membrane30 and importance in nisin antimicrobial 
activity has been established through bioengineering studies29–32. These studies suggest a preference for small, 
chiral amino acids in that region31. Nisin H has an aromatic polar tyrosine instead of the non-polar methionine 
in the second position. Nisin P has two changes in the hinge region, with an exchange of a polar asparagine for 
a non-polar alanine, and an exchange of methionine with an isoleucine, both non-polar amino acids. Directed 
amino acid changes in nisin A showed that alanine in position 21 reduced bioactivity against methicillin resistant 
Staphylococcus aureus ST528, S. aureus DPC5245 and S. agalactiae ATCC13813 to half of the bioactivity from 
nisin A; however, molecules carrying an isoleucine in position 22 showed an enhanced bioactivity against the 
three microorganisms32. Nisin P might also receive a benefit from the presence of a lysine residue in position 4 
instead of isoleucine, as previous studies have shown that the presence of an additional positive charge in ring A 
has a positive effect on activity27. Further studies are required to determine if there are indeed instances where 
nisin P benefits by virtue of these changes.
Cross-immunity assays indicated that nisin P was able to inhibit the growth of the nisin A and nisin U produc-
ers, suggesting that their immunity systems are so different as to not provide protection from the effect of nisin P. 
S. agalactiae DPC7040 was also very sensitive to nisin A. Nisin P and nisin A inhibited the growth of the nisin U 
producer, S. uberis strain 42. Although the impact of nisin A against this strain has been reported previously15, it 
contrasts with initial reports that S. uberis strain 42 was cross-resistant to nisin A13. Nisin A and nisin P were not 
able to inhibit the growth of S. hyointestinalis DPC6484, the nisin H producer, an observation previously made 
in the case of nisin A15. S. hyointestinalis DPC6484 does not have one of the two systems involved in lantibiotic 
immunity, NisI. NisI has been reported to have a more crucial role in immunity than the NisFEG ABC trans-
porter system, which was considered to provide around 20% of the wildtype immunity33–35. However, another 
study highlighted that nisI expression provided a very low level of immunity (1–4%)36. Regardless, the immunity 
of S. hyointestinalis DPC6484 against other nisin peptides despite the low levels of similarity of NshFEG to the 
homologues from the nisin A, P and U producers is somewhat surprising.
Domain Tryptic peptide m/z (1+) MC PSMs CAM
Highest 
probability (%)
N-term VTSKSLCTPGCK 1,207.58 1 342 145 100
N-term VTSKSLCTPGCKTGILMTCAIK 2,162.09 2 6 2 7
Core TGILMTCAIK 1,029.54 0 37 0 —
Core SLSLCTPGCKTGILMTCAIK 1,820.91 1 4 0 —
Full VTSKSLCTPGCKTGILMTCAIKTATCGCHFG 3,003.39 3 17 1 23
C-term TGILMTCAIKTATCGCHFG 1,984.88 1 144 70 100
C-term TATCGCHFG 916.3329 0 91 52 100
Table 2. List of peptides obtained by digestion with trypsin and LC-MS/MS analysis. MC: Missed cleavage. 
PSMs: Peptide Spectra Match.
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Figure 6. MS/MS spectra for nisin P peptides obtained by trypsin digestion and generated in Scaffold (v4.4.1.1, 
www.proteomsoftware.com). b- ions are represented in red and y- ions in blue. (A) Spectrum of nisin P showing 
fragmentation only in linear region, indicating presence of all rings. (B) Spectrum showing presence of ring A 
(C is free and there is no fragmentation) and absence of ring B (C has a CAM modification and is fragmented). 
(C) detail of presence of ring C and hinge region, AIK (D). Presence of ring D and CAM modification 
indicating the absence of ring E.
Figure 7. Fully modified structure of nisin P. Locations of the sites in nisin P cleaved by trypsin to form the 
different peptides summarized in Table 2 are indicated by arrows, * indicates that the ring is not always formed.
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From an autoinduction perspective, in addition to having a lower antimicrobial activity, nisin P also required 
higher concentrations to activate the nisin A promoter. However, this might be due to the specificity of the mol-
ecule or the receptor. Given the structural differences between the nisin variants of lactococcal and streptococcal 
origin, it would be interesting to investigate if using different nisin inducers with cognate receptors impacts on 
levels of induction.
In conclusion, the study of both bioengineered and natural variants of nisin aids the understanding of 
structure-activity relationships of this molecule and that knowledge can be applied to other lantibiotics and to 
the further development of more efficient antimicrobials. Nature provides a nisin variation system and previously 
unknown nisin variants continue to be discovered. The wide dissemination of the clusters encoding this molecule 
could be linked to its ability to provide a competitive advantage and increased fitness. Future investigation of nisin 
P modification and production in mixed communities might help to establish further knowledge on whether it 
would be a good candidate as an antimicrobial agent in certain environments.
Materials and Methods
Bacterial strains, media and culture conditions. Bacteria were sourced from culture collections 
(ATCC, American Type Culture Collection, NCTC, National Collection of Type Cultures) and in-house col-
lections at Teagasc and Quadram Institute Bioscience. L. lactis NZ 9800 (nisin A producer) and L. lactis NZ 
9000 pNZ8150 gfp+ DPC7179 were grown aerobically at 30 °C in GM17 (Oxoid - CM0817). All other bac-
teria were cultured at 37 °C. S. uberis strain 42 (nisin U producer), S. hyointestinalis DPC6484 (nisin H pro-
ducer) and S. agalactiae DPC7040 (nisin P producer) were grown in BHI (Merck – 110493) anaerobically, as were 
indicator strains Cronobacter sakazakii NCTC 11467, Clostridium perfringens NCTC 3110 and Listeria innocua 
NCTC 11288. Listeria monocytogenes 3564, Pseudomonas aeruginosa 2064 APC, Staphylococcus aureus 7016, 
Staphylococcus capitis 20G, Staphylococcus simulans 2B10 and Staphylococcus epidermidis 99 were grown aerobi-
cally in BHI; Salmonella enterica LT2 and Escherichia coli ATCC 25922 were grown anaerobically in LB (Merck – 
110285); Lactobacillus bulgaricus LMG 6901, Enterococcus faecalis LM1, E. faecalis LM4, Lactobacillus gallinarum 
Lac 43, Lactobacillus frumenti Lac 53, Lactobacillus reuteri Lac 54, L. reuteri Lac 56, Lactobacillus paracasei Lac 
R1, Lactobacillus plantarum Lac 29 and Lactobacillus mucosae Lac 28 were grown anaerobically in MRS and 
Enterococcus faecium 4955 was grown in MRS (Oxoid - CM0361) aerobically. Anaerobic growth was performed 
in an anaerobic chamber (Don Whitley, UK) in an atmosphere of 5% CO2, 10% H2 and 85% N2.
Genomic analysis of S. agalactiae DPC7040. S. agalactiae DPC7040 was isolated from a human fae-
cal sample of a male donor with body mass index of less than 25. Initial culture was performed anaerobically 
at 37 °C for 48 h using Wilkins-Chalgren anaerobe agar (Oxoid - CM0643). A genomic library was prepared 
from gDNA using the Nextera XT DNA library preparation kit (Illumina, USA). Whole genome sequencing 
was performed using Illumina’s MiSeq platform with the MiSeq V3 600 cycles Paired Ends kit using paired-end 
2×300 bp reads. The quality reads examination and the trimming of low-quality bases and Illumina adaptors 
were conducted using FastQC and Trim-Galore37. Assembly of contigs from paired-end reads was achieved using 
Figure 8. Stability of nisin A (A), P (B) and H (C) stored at different pH for 24, 48 and 72 h measured by radius 
(mm) of inhibitory activity against L. bulgaricus LMG 6901 using well-diffusion assay. Results are the mean of 
triplicate measurements +/− standard deviation.
Strain Activity nisin P Activity nisin A MIC nisin P MIC nisin A
L. lactis
NZ9800 (nisin A) ++ + 8.5 μM 26 μM
S. uberis
strain 42 (nisin U) ++ +++ 4.25 μM 0.4 μM
S. hyointestinalis
DPC6484 (nisin H) − − − −
S. agalactiae
DPC 7040 (nisin P) + +++ 17 μM 0.022 μM
Table 3. Summary of inhibitory activity of nisin P and A against different natural nisin producers. −, No 
activity; +, 1 mm radius inhibition zone; ++, 1–5 mm radius inhibition zone; +++, >5 mm inhibition zone.
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SPAdes38. Bacteriocin operons were identified using BAGEL339 and manually curated using Artemis40. Accession 
number for S. agalactiae DPC7040 is WIDP00000000. The S. agalactiae pan-genome was constructed by down-
loading all available genomes labelled “Streptococcus agalactiae” from the PATRIC database (30/08/2019). The 
genomes identified as non-S. agalactiae using Kraken2 (v. 2.0.7) and PhyloPhlAn (v. 0.99)41 were removed from 
the analysis, leaving 993 genomes that were annotated using Prokka (v.1.11). A pangenome was constructed 
using Roary (v. 3.12.0)42 using default parameters, and Scoary43 was used to perform pangenome-wide associa-
tions for stool vs. non-stool, and to look for genes significantly associated with stool isolates. Blastp44 was used 
to manually annotate genes with significant associations using the pangenome reference sequences produced by 
Roary. A phylogenetic tree was built using PhyloPhlAn (v. 0.99)41 and visualized using GraPhlAn45. Principal 
Coordinates analyses (PCoA) were performed using the presence/absence output from Roary analysis, converted 










S. enterica LT2 − − − −
E. coli ATCC 25922 − − − −
C. sakazakii NCTC 11467 − − − −
C. perfringens NCTC 3110a − − − −
L. innocua NCTC 11288 − − − −
L. bulgaricus LMG 6901 +++ +++ 0.01 μM 0.0005 μM
L. monocytogenes 3564 − ++ − −
E. faecium 4955 ++ +++ 0.265 μM 0.1 μM
E. faecalis LM1 − ++ − 6.5 μM
E. faecalis LM4 − ++ − 6.5 μM
P. aeruginosa 2064 APC − − − −
S. aureus 7016 ++ +++ 0.531 μM 0.05 μM
S. capitis 20G ++ +++ 8.5 μM 0.812 μM
S. simulans 2B10 ++ +++ 0.531 μM 0.325 μM
S. epidermidis 99 + +++ 34 μM 0.812 μM
L. gallinarum Lac43 + ++ 8.5 μM 0.812 μM
L. frumenti Lac53 +++ +++ 1.06 μM 0.27 μM
L. reuteri Lac54 + ++ 8.5 μM 0.812 μM
L. paracasei LacR1 ++ +++ 17 μM 1.62 μM
L. plantarum Lac 29 +++ +++ 1.06 μM 0.1 μM
L. mucosae Lac28 +++ +++ 1.06 μM 0.54 μM
L. reuteri Lac 56 + ++ 69 μM 3.25 μM
Table 4. Summary of inhibitory activity of nisin P and A. aC. perfringens NCTC 3110 has usually been reported 
to be sensitive to nisin A. −, No activity; +, 1 mm radius inhibition zone; ++, 1–5 mm radius inhibition zone; 
+++, >5 mm inhibition zone.
Figure 9. Total bacteria after nisins A, P and H treatments measured by 16 S rDNA qPCR after faecal 
fermentation at 8 and 24 h. Two concentrations of peptide were tested, 15 µM and 50 µM. Half of the wells 
received a second dose of the same concentration at 8 h. Results are the mean of duplicate measurements +/− 
standard deviation. Statistics was conducted with live cells data: a, indicates significant difference between the 
treatment and the blank at 8 or 24 h; b, indicates significant difference between 15 µM and 50 µM concentrations; 
c, indicates significant difference between 8 and 24 h within the same nisin treatment (p < 0.05).
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on the accessory genome of the species. The principal coordinate model was built based on Jaccard distance 
between each accessory genome using the ‘vegan’ package (v. 2.5–1)46 and visualized using ggplot2 (v. 2.2.1)47. 
Additionally, LanB and LanC were searched manually in genomes of the 12 stool isolates S. agalactiae GBS10, 11 
and 12 and MC625 to MC629 and MC631 to MC634.
Purification of nisin A, H and P. Nisin P production required initial induction with 500 ng/ml of nisin 
A, which was not included in subsequent S. agalactiae DPC 7040 subcultures. Nisin P was purified from 2 l 
of S. agalactiae DPC 7040 grown anaerobically in BHI for 48 h (2.0 × 108 cfu/ml). Supernatant was obtained 
by centrifuging the culture at 8000 × g, 10 min. Culture supernatant was applied to a 30 ml SP Sepharose col-
umn pre-equilibrated with 20 mM sodium acetate pH 4.4. The column was washed with 100 ml of 20 mM 
sodium acetate pH 4.4 and then eluted with 150 ml of 20 mM sodium phosphate buffer pH 7 containing 1 M 
NaCl. The NaCl-containing eluate was applied to a 60 ml, 10 mg Strata–E C18 SPE column (Phenomenex, UK) 
pre-equilibrated with methanol and water. The column was washed with 60 ml 30% ethanol and antimicrobial 
activity eluted with 70% 2-propan-ol 0.1% TFA (IPA). Antimicrobial activity of eluents from purification steps 
were tested via well-diffusion assay: indicator plates were prepared by adding 100 µl of an overnight culture of the 
indicator strain to 20 ml of melted agar, then 50 µl of each test solution was added to wells made in the agar and 
plates were incubated overnight at 37 °C using the conditions required by the indicator strain.
The IPA was removed from the C18 SPE eluent by rotary evaporation and sample applied to a semi prepara-
tive Proteo Jupiter (10 × 250 mm, 90 Å, 4 µ) RP-HPLC column (Phenomenex, Cheshire, UK) running a 30–37% 
acetonitrile 0.1% TFA gradient where buffer A was 0.1% TFA and buffer B was 100% acetonitrile, 0.1% TFA. The 
eluate was monitored at 214 nm and fractions were collected at intervals. Nisin P-containing fractions deemed 
pure by Matrix-Assisted Laser Desorption/Ionization-Time Of Flight (MALDI-TOF) mass spectrometry (MS) 
were lyophilised using a Genevac lyophiliser (Suffolk, UK).
Nisin H was purified from 2 l of culture (1.2 × 108 cfu/ml) grown overnight at 37 °C in TSB (Oxoid) without 
induction and purified as for nisin P except a 25–40% acetonitrile 0.1% TFA gradient was used for HPLC puri-
fication. Nisin A was purified from nisin A supplied by Handary SA (Belgium) by reversed phase HPLC using a 
25–45% acetonitrile 0.1% TFA gradient as described above.
Nisin P, H and A HPLC fractions containing antimicrobial activity against L. bulgaricus LMG 6901 were 
analysed via MALDI-TOF MS to confirm the molecular mass of the antimicrobial peptide and to assess peptide 
purity. HPLC fractions deemed pure by MALDI-TOF MS were combined and lyophilised in a Genevac lyoph-
iliser. MALDI-TOF MS was performed with an Axima TOF2 MALDI-TOF mass spectrometer in positive-ion 
reflectron mode (Shimadzu Biotech, UK).
Nisin P structural analysis. The intact peptide was analysed by LC-MS on a Synapt G2-Si mass spectrom-
eter coupled to an Acquity UPLC system (Waters, UK). Aliquots of the sample were injected onto an Acquity 
UPLC BEH C18 column, 1.7 µm, 1×100 mm (Waters, UK) and eluted with a gradient of 1–50% acetonitrile in 
0.1% formic acid in 9 min and then ramped to 100% acetonitrile in 1 min at a flow rate of 0.08 ml/min with a 
column temperature of 45 °C.
The LC-MS was operated in positive MS-TOF resolution mode and with a capillary voltage of 3 kV and a cone 
voltage of 40 V in the range of m/z 100–2000. Leu-enkephalin peptide 0.5 µM (Waters - 186006013) was infused 
at 10 µl/min as a lock mass and measured every 20 s. Masslynx 4.1 software (Waters, UK) was used to generate 
the spectra by combining several scans. The peaks were centered, and the mass calculated from the monoisotopic 
peak.
For structure confirmation, purified nisin P was digested with trypsin (Sigma) and analysed using 
nanoLC-MS/MS on an Orbitrap Fusion Tribrid Mass Spectrometer coupled to an UltiMate 3000 RSLCnano LC 
system (Thermo Scientific, UK). To investigate ring formation, samples were treated with iodoacetamide to alky-
late free cysteine residues. The samples were loaded and trapped using a pre-column which was then switched 
in-line to the analytical column for separation. Peptides were separated on a nanoEase m/z column (HSS C18 T3, 
100 Å, 1.8 µm; Waters, UK) using a gradient of acetonitrile at a flow rate of 0.25 µl/min with the following solvent 
steps A (water, 0.1% formic acid) and B (80% acetonitrile, 0.1% formic acid): 0–4 min 3% B (trap only); 4–15 min 
increase to 13% B; 15–77 min increase to 38% B; 77–92 min increase to 55% B; followed by a ramp to 99% B and 
re-equilibration to 3% B.
Data dependent analysis was performed using parallel CID and HCD fragmentation with the following 
parameters: positive ion mode, orbitrap MS resolution = 60k, mass range (quadrupole) = 300–1800 m/z, MS2 
top20 in ion trap, threshold 1.9e4, isolation window 1.6 Da, charge states 2–5, AGC target 1.9e4, max inject time 
35 ms, dynamic exclusion 1 count, 15 s exclusion, exclusion mass window ±5 ppm. MS scans were saved in profile 
mode and MS2 scans were saved in centroid mode.
1 mg/ml 10 ug/ml 1 ug/ml 500 ng/ml 100 ng/ml 50 ng/ml 20 ng/ml 10 ng/ml 5 ng/ml 2 ng/ml 1 ng/ml
Nisin P — 1758.33 ± 41.66 658.33 ± 8.33 316.66 ± 33.33 75 ± 8.333 — — — — — —











± 25 — — —
Table 5. Fluorescence levels of nisin induction of L. lactis NZ9000 pNZ8150 gfp+ by nisin P, A and H.
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MaxQuant 1.6.2.3 was used to generate recalibrated peaklists, and the database search was performed with 
the merged HCD and CID peak lists using Mascot 2.4.1 (Matrixscience, UK). The search was performed, with 
a precursor tolerance of 6 ppm and a fragment tolerance of 0.6 Da, on a S. agalactiae protein sequence database, 
which included the nisin P gene cluster (Uniprot, January 2018, 2,123 sequences) to which the nisin P peptide 
sequence had been added. The enzyme was set to trypsin/P with a maximum of 2 allowed missed cleavages (MC). 
Dehydration (−18 Da) of serine and threonine, oxidation of methionine and carbamido-methylation (CAM, 
+57 Da) of cysteine were set as variable modifications. The Mascot search results were imported into Scaffold 
4.4.1.1 (www.proteomsoftware.com) using identification probabilities of 99% for proteins and 95% or 0% for 
peptides, as discussed in the results.
pH stability of nisin P compared to nisin H and A. Nisin P, A and H were resuspended at 1 µg/ml in 
distilled water. Duplicate samples at pHs 3, 5, 6, 7 and 8 were prepared for each nisin. Antimicrobial activity was 
tested at 24, 48 and 72 h via well-diffusion assay using L. bulgaricus LMG 6901 as indicator.
Cross- immunity assays. Cross immunity assays were conducted by well diffusion assay to test the activity 
of the purified nisin P and nisin A against natural nisin A, P, H and U producers. 100 μl of an overnight inoculum 
of each indicator strain was added to 20 ml of melted agar media. 50 μl of pure peptides at 0.20 mg/ml were added 
to a well pre-formed in the agar and incubated overnight according to the growth requirements of the different 
nisin producers used as indicator strains. Growth of the indicator strain in the presence of peptide was taken as 
confirmation of immunity. Blastp analysis44 was performed on the proteins responsible for the immunity system, 
NisF, functioning as an ATPase, and NisE and NisG, the membrane spanning domains of the transporter, of nat-
ural producers of nisin A, P, H and U.
Spectrum of inhibitory activity. The inhibitory activity of nisin P compared with nisin A against a range 
of indicator strains was determined by well diffusion assay. 50 µl of the purified peptides at a concentration of 
0.2 mg/ml were added to wells preformed in the indicator plates, which were incubated overnight according 
to growth requirements of the indicator strain. Inhibitory activity was determined by the presence of a zone of 
inhibition.
Minimum inhibitory concentration (MIC) assays. 96-well plates (Sarstedt, UK) were pre-treated with 
bovine serum albumin (BSA) on the day of assay. For this purpose, 0.5 g of BSA (Sigma, UK) was mixed with 
2.5 ml of 20X phosphate buffered saline (PBS, Sigma, UK). Water was added to the mix for a total volume of 50 ml. 
200 µl were added to each well and the plate was incubated for 30 to 45 mins at 37 °C. After this time, BSA was 
removed and the wells washed with 1X PBS and air dried in a sterile hood. For MICs, peptide concentrations of 
4X the highest test concentration were prepared in 350 µl of the growth media required for the target strain to 
grow, and 100 µl of this mix was added to the first well of each row. 100 µl of the same media were added to each 
well and 2-fold serial dilution was performed alongside the row. After this, 100 µl of culture inoculated with the 
target strain was added to each well. To prepare this inoculum, an overnight culture was sub-cultured the day of 
the assay and incubated until an optical density (OD600) of 0.5 was reached. The culture was diluted 1:10 and 20 µl 
of this added to 980 µl of media. 150 µl of this new mix was added to 14.85 ml of growth media. The objective was 
to standardise the final inoculum to 105 cfu/ml in 200 µl. The plate was incubated under the requirements of the 
target strain, and MIC determined as the lowest peptide concentration where there was no growth of the target 
strain. OD600 was measured using a Synergy HT Microplate reader (BioTek, UK).
MicroMatrix fermentations. Preparation of a faecal standard. A faecal standard for fermentation in a 
MicroMatrix was prepared following methodology described by O’Donnell et al.48. Faecal samples were provided 
by different donors, from a study approved by the Clinical Research Ethics Committee of the Cork Teaching 
Hospitals, UCC, (ECM 4 (k) 04/12/18). The samples of six healthy donors with no antibiotic treatment in the 
previous six months were collected and maintained at 4 °C for 1–2 h before being transferred to an anaerobic 
chamber (5% CO2, 10% H2 and 85% N2) for processing. 200 g of faeces were placed in a Circulator 400 stomacher 
bag (Seward, UK) with 200 ml of PBS containing 0.05% (w/v) cysteine hydrochloride. After filtering and homog-
enizing, the faecal slurry was centrifuged (4000 × g, 25 min) and resuspended in PBS. Sterile glycerol was added 
to the mix to a final concentration of 25% and aliquots were stored at −80 °C until required.
MicroMatrix fermentation. Faecal standards were defrosted at 37 °C before use and prepared at 10% concen-
tration in faecal medium as described by Fooks and Gibson49. 2 ml of the mix were added to each well of a 
MicroMatrix 24-well cassette (Applikon Biotechnology, Netherlands). Purified nisin A, P and H were added 
to the wells to final concentrations of 15 or 50 µM. Fermentations took place for 24 h at 37 °C, with pH of the 
medium adjusted and maintained at 6.8 in a MicroMatrix fermenter (Applikon Biotechnology). At time point 
8 h, half of the nisin-treated wells received an additional dose of nisin A, P and H at the same concentration as at 
time 0 h. 500 μl aliquots were withdrawn from each well at time points 0, 8, 24 h (T0, T8, T24) and kept frozen for 
further analysis.
qPCR. 200 μl aliquots from each MicroMatrix fermentation were taken for DNA extraction using QIAmp Fast 
DNA Stool Mini Kit (Qiagen, Crawley, UK), following the manufacturer’s instructions. To compare total cell 
numbers with live cells, ethidium bromide monoazide (EMA, Sigma, UK) treatment was performed by adding 
EMA to the sample at a concentration of 10 µg/ml, incubating the samples in darkness for 5 min and exposing 
them to 70-Watt HQI light for 10 min at 20 cm while keeping the samples on ice50. Samples were then centrifuged 
at 12000 × g for 5 min and the supernatant discarded before proceeding with the standard DNA extraction with 
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QIAmp Fast DNA Stool Mini Kit. Absolute quantification by qPCR was performed to determine bacterial num-
bers, using the Roche LightCycler 480 II platform. Although bacteria can have multiple copies of rDNA51, we 
used the amplification of this gene as a reference to measure the effect of the different treatments. To quantify 16 S 
bacterial counts, a standard curve was created using 1000 to 100 copies of 16 S rDNA/μl. For amplification, 16 S 
rDNA primers used were CO1 forward primer (5′-AGTTTGATCCTGGCTCAG-3′), and CO2 reverse primer 
(5′-TACCTTGTTACGACT-3′)52 with KAPA Lightcycler 480 mix (KAPA Biosystems Ltd., UK) according to 
manufacturer’s instructions. All samples were run in triplicate.
Statistical analysis. Significant differences between groups were established using a paired t-test, assuming 
normal distribution, equal variances. Both sides of the distribution were considered. Significance was considered 
when P value was <0.05. Calculations were performed using Excel 365.
Activity induction. Induction experiments were performed using L. lactis NZ9000 pNZ8150 gfp+, where 
gfp acts as a reporter of expression from a nisin A inducible promoter53. An overnight culture of this strain was 
diluted 1:100 into fresh media and incubated until the OD600 reached 0.5. Purified nisin P, A and H were added 
to 1 ml of GM17 at a concentration of 1 mg/ml, 10 μg/ml, 1 μg/ml, 500, 100, 20, 10, 5, 2 and 1 ng/ml and 20 µl of 
the L. lactis NZ9000 pNZ8150 gfp+ were added to the mix. 200 µl were transferred to black 96-well plates (Nunc, 
Thermo Fisher, UK) and GFP was detected using a Synergy HT Microplate reader (BioTek, UK). The excitation 
filter was set at 485 nm and the emission filter at 528 nm.
Ethics declaration. Faecal samples were provided by different donors, from a study approved by the Clinical 
Research Ethics Committee of the Cork Teaching Hospitals, UCC, (ECM 4 (k) 04/12/18). All methods were 
carried out in accordance with relevant guidelines and regulations. All participants (aged 18–65) provided their 
written informed consent to participate in this study.
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